Tolerability and Clinical Activity of Post-Transplantation Azacitidine in Patients Allografted for Acute Myeloid Leukemia Treated on the RICAZA Trial

Disease relapse is the major causes of treatment failure after allogeneic stem cell transplantation (SCT) in patients with acute myeloid leukemia (AML). As well as demonstrating significant clinical activity in AML, azacitidine (AZA) upregulates putative tumor antigens, inducing a CD8(+) T cell resp...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biol Blood Marrow Transplant
Main Authors: Craddock, Charles, Jilani, Nadira, Siddique, Shamyla, Yap, Christina, Khan, Josephine, Nagra, Sandeep, Ward, Janice, Ferguson, Paul, Hazlewood, Peter, Buka, Richard, Vyas, Paresh, Goodyear, Oliver, Tholouli, Eleni, Crawley, Charles, Russell, Nigel, Byrne, Jenny, Malladi, Ram, Snowden, John, Dennis, Mike
Formato: Artigo
Idioma:Inglês
Publicado em: Carden Jennings Publishing 2016
Assuntos:
Brief Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4728172/
https://ncbi.nlm.nih.gov/pubmed/26363443
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2015.09.004
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados